Clinical Trial Update: Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

View source ↗

Summary

A completed clinical trial evaluating quality assurance of secondary immunodeficiencies in patients with chronic lymphocytic leukemia or multiple myeloma; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Multiple Myeloma

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Secondary Immunodeficiencies (SID) | Status: COMPLETED | Results posted: 2022-01-10